Northwest Biotherapeutics Inc (QB) (NWBO) ニュース

I'm now 63 years of age. It does for whatever reason give me hope that I may see this through to be successful given others ages. It seems like myself there are a lot of others that are " seniors " . How old are we if u dare to post your ages .?
I also think Tyson was paid off , he's old but not dead and a hook would have put an end to Paul.

Clearly NOT. NWBO gets paid for patients on com[passionate care programs. Advent's rate card for DCVax-L compassionate care is $250K. And NWBO has not shown any material revenue so clearly they are not treating many patients as all -- whether UK or U.S.

Once again, you seem to ignore the fact that Dr. Liau chose PFS as the lead primary endpoint in the UCLA/SPORE clinical trial. Certainly not B.S. Read the clinicaltrials.gov trial protocol.

If you mean by 'yet' = today (more or less) you qualify again as one of the chief-idiots
among the shorters : The 10Q is per end September 2024 !
Today is end November 2024, so how do you KNOW that by now this isn't done 'YET' ?

Continue with your fudster-posts, you'll be remembered !

Betting? You mean something like gambling?

How could I have full conviction that this is a completely derisked investment? Does your friend know what the best medicine looks like?

You can forget about BO. It won't happen.

flipper44,

Poly might be used during L activation/maturation at a later date to improve or guide uptake of tumor derived or associated antigens which might reduce the amount of tumor tissue needed to make vaccines with. For the time being we know it will be used as it was in the trials it has been involved in. Best wishes.

tryn2,

Good to have you back again. Good time to bring out the old mantra “stay tuned”; ). Looks like anytime up to about 4 weeks for ruling on motion to dismiss and from now up to 9 weeks for MHRA decision seems most likely. Best wishes.

Tax loss selling would be more attractive if not limited by the $3,000 yearly limit.

No one cares. LP is happy to dilute at .30 cents and thats the reality. 2+ years since JAMA, TLD. 4+ years since data lock. But continue to live in denial.

Markets need to be reformed and our lawsuit moves that process forward. However I do not think we will see new regulations or additional enforcement actions given the change in administration. The new policies seem to entail dismantling a large part of the Federal Government. So that's an issue as these oligarchs are not going to dismantle their own businesses. The new administration will aid in approval, being antiestablishment and rebellious, but we're not going to see changes in market operations especially the concentration of volume in a few large institutions.

Who DAT say they gonna beat Linda Powers?

Gus1212,

Add in INMune Bio and a big backer or group like the Cognate buyout had and it’s a wrap; ). Best wishes.

Huh, don't know what you are on about?

Please speak the Queens English, thanks.

pouting
/'pa?t??/
adjective
adjective: pouting

pushing one's lips or one's bottom lip forward as an expression of annoyance or in order to look sexually attractive.
"images of nubile, pouting models"
(of the lips) pushed forward.
"a picture of pouting lips wearing glittering red lipstick"

I am trading in Singapore and my platform have stopped me buying more, I can keep what I have for as long as I like, but I can't buy a single share more.

Never mind, I have the amount I am comfortable owning, despite heavy loss so far.

No matter what, good luck to us all.

Cancer survivor myself, so I hope we will see DCV +poly available for many cancer types.

I have been all in Nwbo, I am waiting MTD or approval in UK then broad francise. I thought at least $2 after approval in UK, then might be $10++ after announced Broad franchise. Just Saying.

Guzzi, if someone did that you'd be pouting that you should have had more. 

I have more than I ever thought I would, some is intended for tax loss selling, but if we get news before the new year that buoys the stock above $1, I will keep it all.  $10 to $20 billion market cap or buyout is very possible in the next few years, but we need production capabilities and approvals before it happens. 

Gary 
 

I fully agree.

Betting all your money here is risky, very risky.

I don't have much invested here for the same reason.

A friend that done very well on the stock market stays far away from OTC stocks NO MATTER IF THEY GOT THE BEST EVER SEEN MEDICINE THE WORLD HAVE EVER SEEN!! LOL.

A 27 cent stock company, right!!!!!!!!

Please can someone BO this at 10-15 billion, preferable before Christmas, thanks.

New revelations about Coffer Black: He "helped the French capture Carlos the Jackel", and tried along with his boss George Tenent to get the JW Bush administration to move against Al Kaida before 9/11.
Black, a charismatic ex-operative who had helped the French arrest the terrorist known as Carlos the Jackal, says the GW Bush team just didn’t get the new threat

see: https://www.politico.eu/article/attacks-will-be-spectacular-cia-war-on-terror-bush-bin-laden/

Yet the shorts insist he did nothing for NW like getting the goods on the MMs. Oh, 'he's just not that kind of guy'. ROFLMAO! I'd say the shorts have the proverbial paper bag over their heads just like Bush did (of "now watch this drive" fame). I think the shorts are waiting for their own 9/11-level surprise here.

Printing shares doesn't help either.

I wish they could find another way of keeping the lights on.

It's a bit worrying to me if that's not possible?

12 years! That is a long time. You will be rewarded abundantly and the rewarding will happen soon.

But as I keep digging, I realize the potential of this company is far beyond I could imagine and the long waiting is totally worth it. Well said.

Projecting is never positive

How can they dilute 1 million a day if there is volume between 1-2 million 

Stinking POS.

Probably not us but our grand grand kids will see fda approval. Probably, LP still the CEO. 🤦🏽.

Been holding 12 years +. I hope I live long enough to see it approved.

Let's put aside this trashy trial for a moment.

Enlighten me if you can: To make immunotherapy work for cancer, which part is the most essential?

Hope this question is not too hard.

Yes they are evaluating the results of the experiments using Edens.
Wow, Eden must be working so well that NWBO/Booster Company would enter into a commercial in-license contract.

Horse,

Lifetime learning is a wonderful way to live!
This is so true. Never thought I had to hold NWBO for this long (three years). But as I keep digging, I realize the potential of this company is far beyond I could imagine and the long waiting is totally worth it. This is and will be the only one I hold for a very long time.

The longs are trapped bagholders. We are the cult followers. Dude, you made me laugh.

You have been busy writing BS all week and hope you take a break and enjoy your weekend.

The expression "bag holding" evokes a different connotation for me. Not only seeing the SP way below break even, but more importantly, seeing the stock's best days in the rearview mirror. Now that's a torturous scenario. Message boards are filled with professional whiners, just like $Amrn, where not even an investment of $124 million from an activist fund, and purging the BOD made any difference. How's that fund feel now, with an average of $3.50ish, and the stock stuck in the $.50's range at all time lows?

Manibio made light of NWBO 's continued patent fortification. Ask $Amrn investors how they feel about Generics hoodwinking the court with a doctored trial graph, which an inexperienced first time bench Judge cited, as the linchpin that lost $Amrn it's skinny label patent. I'll leave it there.

So when dstock shows us new revelations on the benefits of using DC's, and Henry posting the growing patent portfolio, and someone suggests "bag holding," I'm thinking, WOW, they have no idea.

You forgot to quote the whole sentence that came from
The corresponding 1, 2, 3, and 4-year OS rates stood at 79.2%, 42.4%, 31.5%, and 27.7%
Tumor Treating Fields (TTFields) therapy has shown significant promise for improving long-term survival in patients with glioblastoma, as evidenced by various studies, including the EF-14 trial and the recent German TIGER study. The EF-14 trial demonstrated that adding TTFields to standard chemotherapy significantly improved the 5-year overall survival (OS) rate to 13%, compared to just 5% with chemotherapy alone. Median OS with TTFields was reported as 20.9 months, versus 16.0 months with temozolomide alone.

You see how fast that OS is declining and that study did NOT exclude the non GBM mutants

DCVAXL has an OS after 5 years of 13% as well and holding years after that and DCVAX JAMA article did exclude the non GBM mutant

From the 10Q---If this was brought up previously I missed it-in bold.
And maybe this:
The parties are now evaluating the results and developing plans for further experiments.

So not yet done.

From the 10Q---If this was brought up previously I missed it-in bold.

The Company has also completed negotiations and entered into a contract with a company that has an immune booster agent that may have the potential to further increase the potency of DCVax products. The contract provides for material supply and in vitro testing of the booster agent with DCVax products. If the in vitro testing is successful, the parties plan to enter into a license of the booster agent to NWBio. The parties jointly designed the program of experiments, and the experiments were carried out and completed by the Flaskworks team. The parties are now evaluating the results and developing plans for further experiments.

Blessings in disguise as bagholders can scoop more shares. LP is a master tactician this is all her strategies to trapped shorts. Oh wait they've been telling the same narrative since my first nwbo share purchased in 2016.

Do you mean bagholders trapped in this bottomless pit. You cult followers always see reality from opposite perspectives, don't you?

Another beautiful day in NWBO LAND. Down 4 plus % . What a bunchof liars at NWBO

Um ... look more closely. These were IDH-1 mutant Gr IV astrocytomas, Not GBMs. Better survival in this cohort. Please try again.
You are absolutely correct that that study does not apply as it is for IDH mutant..

Can we try the RWE study that does apply? The German Tiger P4?

N=429
MOS 19.6 months
4 year OS 27.7%

Since it has been well established that TTF is junk, what does that make -L numbers?

Lifetime learning is a wonderful way to live!

NWBO has provided me a PhD of sorts, Pharma process Delays

And LP has been navigating such as to maximize overall process efficiency like one SAP, morphing a phase2 into a phase 3, after UK approval nwbo takes dcvaxL on a multi nation approval tour, and assembling and buttressing an IP and closed system manufacturing moat around the platform and franchise. 

Pre revenue commercialization just takes a long, long, time in general. 

NWBO is my last such investment and hopefully the grand slam we expect it to be!!!

If predicting could kill, many of the LP followers would already be dead by now. 🤣

No approval=> wrong within the next 8 weeks DCVAXL will be approved

For the major RAs=> right after UK NWBO will submit to RMA and 6 to 9 months later EMA will follow swiftly with approval

For UK, no flans on commercialization=> just wait what they have to say about that after UK approval> I bet the have licensed the sales to a bif phrama.

Eden in limbo land.=> wrong Eden is now vitro testing of the booster agent with DCVax products.
The parties jointly designed the program of experiments, and the experiments were carried out and completed by the Flaskworks team
and on its way to be approved fairly soon
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification

as per usual you are wrong on all accounts

I cannot believe you are naive to such an extent that you want to see NWBO as the collaborator. Are you dreaming? If everything is direct and obvious, how could LP trap you and your buddies deep in a bottomless pit?

Is this what you believe? Have you seen what kind of trials Oncovir was involved in as either sponsor or collaborator?
And not a single one show NWBO as a sponsor or collaborator.

There is a reason why, you just cannot find that dot connection for some reason.

Um ... look more closely. These were IDH-1 mutant Gr IV astrocytomas, Not GBMs. Better survival in this cohort. Please try again.

Thanks eagle 8.

Abstract CTN1-41 shows real world 5 year ndGBM survival 17% for TTF + SOC vs 11% SOC alone. 210 patients. About a 1:1 split.

Those numbers show the 13% DCvax 60 month survival is inferior and actually closer to the TTF control arm than the TTF treatment arm.

Zadie, here in Holland it takes 1 day for the financial transfer.
When buying I have paid various amounts in the past years but never really much for purchases. Small purchases generally $ 8.90.
Larger purchases up to $ 70, -

I do not find it expensive since I only buy and do not sell, except at a rate above $ 15, - maybe a few.

GLTU

I'm glad it helped, Eagle. I know it gave me much broader ideas of why NWBO was using a continuation patent other than they need more time for something.

Thank you beartrap.
This piece gives a nice and broad overview of the advantages of the patent application.
Very informative.

GLTU

How much do they charge per each transaction? Do you have TO Wait 3 days rule to clear your moony transfer from your bank like Charles Schwab>>>

You mean of course, where the Market Makers will meet their death.

I use interactive brokers since 2015.
I am satisfied with it.

GLTAL